Craig A. Tooman
2018 - Aratana Therapeutics
In 2018, Craig A. Tooman earned a total compensation of $863.6K as Chief Financial Officer at Aratana Therapeutics, a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $110,900 |
|---|---|
| Option Awards | $189,953 |
| Salary | $360,000 |
| Stock Awards | $191,751 |
| Other | $11,000 |
| Total | $863,604 |
Tooman received $360K in salary, accounting for 42% of the total pay in 2018.
Tooman also received $110.9K in non-equity incentive plan, $190K in option awards, $191.8K in stock awards and $11K in other compensation.
Rankings
In 2018, Craig A. Tooman's compensation ranked 9,859th out of 14,244 executives tracked by ExecPay. In other words, Tooman earned more than 30.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,859 out of 14,244 | 31st |
Division Manufacturing | 3,986 out of 5,765 | 31st |
Major group Chemicals And Allied Products | 1,496 out of 2,128 | 30th |
Industry group Drugs | 1,261 out of 1,817 | 31st |
Industry Pharmaceutical Preparations | 969 out of 1,391 | 30th |
Source: SEC filing on April 19, 2019.
Tooman's colleagues
We found two more compensation records of executives who worked with Craig A. Tooman at Aratana Therapeutics in 2018.